Literature DB >> 3990723

Verapamil concentrations in cerebrospinal fluid after oral administration.

A R Doran, P K Narang, C Y Meigs, O M Wolkowitz, A Roy, A Breier, D Pickar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3990723

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Do calcium antagonists have a place in the treatment of mood disorders?

Authors:  C Höschl
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 3.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

4.  Anticonvulsant effects of some calcium entry blockers in DBA/2 mice.

Authors:  G B De Sarro; B S Meldrum; G Nisticó
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

5.  Time-course of changes in water, sodium, potassium and calcium contents of various brain regions in rats after systemic kainic acid administration.

Authors:  L Sztriha; F Joó; P Szerdahelyi
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

6.  Dopaminergic function in rat brain after oral administration of calcium-channel blockers or haloperidol. A microdialysis study.

Authors:  J Reiriz; S Ambrosio; A Cobos; M Ballarín; E Tolosa; N Mahy
Journal:  J Neural Transm Gen Sect       Date:  1994

Review 7.  A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.

Authors:  A Cipriani; K Saunders; M-J Attenburrow; J Stefaniak; P Panchal; S Stockton; T A Lane; E M Tunbridge; J R Geddes; P J Harrison
Journal:  Mol Psychiatry       Date:  2016-05-31       Impact factor: 15.992
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.